INTERPARFUMS, INC. (IPAR) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | (m) | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 1.47M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 259.14M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $1.47M | $259.14M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | (m) | $1.43M | $269.37M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | $1.57M | $270.32M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | (m) | $1.92M | $278.81M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | $2.16M | $276.25M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | $2.35M | $281.90M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $2.38M | $274.80M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | (m) | $2.41M | $257.68M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | $2.43M | $238.88M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | $2.48M | $229.08M | $10.70M | (m) | (m) | 21.40× | Reported |
| 2023-12-31 | (m) | $1.32B | $2.52M | $251.38M | $11.25M | (m) | 0.19% | 22.34× | Reported |
| 2023-09-30 | (m) | (m) | $2.68M | $255.71M | $8.04M | (m) | (m) | 31.81× | Reported |
| 2023-06-30 | (m) | (m) | $2.53M | $232.99M | $6.33M | (m) | (m) | 36.84× | Reported |
| 2023-03-31 | (m) | (m) | $3.12M | $223.37M | $5.07M | (m) | (m) | 44.03× | Reported |
| 2022-12-31 | (m) | $1.09B | $3.14M | $194.30M | $3.60M | (m) | 0.29% | 53.99× | Reported |
| 2022-09-30 | (m) | (m) | $3.05M | $158.89M | $2.07M | (m) | (m) | 76.76× | Reported |
| 2022-06-30 | (m) | (m) | $3.28M | $162.05M | $3.08M | (m) | (m) | 52.53× | Reported |
| 2022-03-31 | (m) | (m) | $2.77M | $161.31M | $3.33M | (m) | (m) | 48.43× | Reported |
| 2021-12-31 | (m) | $879.50M | $2.85M | $148.05M | $2.83M | (m) | 0.32% | 52.41× | Reported |
| 2021-09-30 | (m) | (m) | $3.38M | $186.72M | $3.80M | (m) | (m) | 49.09× | Reported |
| 2021-06-30 | (m) | (m) | $3.29M | $150.44M | $2.25M | (m) | (m) | 66.71× | Reported |
| 2021-03-31 | (m) | (m) | $3.64M | $100.26M | $1.35M | (m) | (m) | 74.49× | Reported |
| 2020-12-31 | (m) | $71.50M | $3.03M | $70.08M | $1.97M | (m) | 4.24% | 35.58× | Reported |
| 2020-09-30 | (m) | (m) | $2.46M | $55.95M | $2.44M | (m) | (m) | 22.91× | Reported |
| 2020-06-30 | (m) | (m) | $2.68M | $61.23M | $2.68M | (m) | (m) | 22.87× | Reported |
| 2020-03-31 | (m) | (m) | $2.56M | $89.22M | $2.52M | (m) | (m) | 35.39× | Reported |
| 2019-12-31 | (m) | (m) | $3.39M | $104.73M | $2.15M | (m) | (m) | 48.80× | Reported |
| 2019-09-30 | (m) | (m) | $3.37M | $102.98M | $2.24M | (m) | (m) | 45.99× | Reported |
| 2019-06-30 | (m) | (m) | $3.03M | $101.31M | $2.38M | (m) | (m) | 42.60× | Reported |
| 2019-03-31 | (m) | (m) | $2.65M | $97.62M | $2.74M | (m) | (m) | 35.60× | Reported |
| 2018-12-31 | (m) | $675.57M | $2.21M | $94.73M | $2.58M | (m) | 0.33% | 36.75× | Reported |
| 2018-09-30 | (m) | (m) | $2.10M | $88.96M | $2.05M | (m) | (m) | 43.37× | Reported |
| 2018-06-30 | (m) | (m) | $2.15M | $87.14M | $2.02M | (m) | (m) | 43.08× | Reported |
| 2018-03-31 | (m) | $619.96M | $2.10M | $82.85M | $2.18M | (m) | 0.34% | 37.95× | Reported |
| 2017-12-31 | (m) | $591.25M | $2.09M | $78.62M | $1.99M | (m) | 0.35% | 39.47× | Reported |
| 2017-09-30 | (m) | $576.50M | $2.05M | $79.19M | $1.65M | (m) | 0.36% | 47.91× | Reported |
| 2017-06-30 | (m) | $564.59M | $1.80M | $78.33M | $1.67M | (m) | 0.32% | 46.82× | Reported |
| 2017-03-31 | (m) | $552.61M | $1.49M | $75.32M | $1.64M | (m) | 0.27% | 45.98× | Reported |
| 2016-12-31 | (m) | $521.07M | $1.20M | $66.68M | $2.34M | (m) | 0.23% | 28.49× | Reported |
| 2016-09-30 | (m) | $504.63M | $903.00K | $65.55M | $3.20M | (m) | 0.18% | 20.51× | Reported |
| 2016-06-30 | (m) | $485.95M | $816.00K | $60.88M | $3.72M | (m) | 0.17% | 16.36× | Reported |
| 2016-03-31 | (m) | $470.81M | $805.00K | $57.67M | $3.64M | (m) | 0.17% | 15.84× | Reported |
| 2015-12-31 | (m) | $468.54M | $787.00K | $61.20M | $2.83M | (m) | 0.17% | 21.66× | Reported |
| 2015-09-30 | (m) | (m) | $757.00K | $61.40M | $1.89M | (m) | (m) | 32.54× | Reported |
| 2015-06-30 | (m) | (m) | $791.00K | $52.44M | $1.40M | (m) | (m) | 37.40× | Reported |
| 2015-03-31 | (m) | (m) | $820.00K | $57.05M | $1.36M | (m) | (m) | 41.85× | Reported |
| 2014-12-31 | (m) | (m) | $856.00K | $53.40M | $1.48M | (m) | (m) | 36.13× | Reported |
| 2014-09-30 | (m) | (m) | $896.00K | $38.19M | $1.55M | (m) | (m) | 24.57× | Reported |
| 2014-06-30 | (m) | (m) | $874.00K | $34.15M | $1.35M | (m) | (m) | 25.24× | Reported |
| 2014-03-31 | (m) | (m) | $856.00K | $29.20M | $1.20M | (m) | (m) | 24.42× | Reported |
| 2013-12-31 | (m) | (m) | $838.00K | $78.75M | $1.38M | (m) | (m) | 57.07× | Reported |
| 2013-09-30 | (m) | (m) | $836.00K | $301.47M | $1.69M | (m) | (m) | 178.70× | Reported |
| 2013-06-30 | (m) | (m) | $828.00K | $308.91M | $1.72M | (m) | (m) | 179.28× | Reported |
| 2013-03-31 | (m) | (m) | $824.00K | $313.64M | $1.75M | (m) | (m) | 179.32× | Reported |
| 2012-12-31 | (m) | (m) | $832.00K | $278.41M | $1.65M | (m) | (m) | 168.33× | Reported |
| 2012-09-30 | (m) | $666.27M | $881.00K | $75.47M | $1.88M | (m) | 0.13% | 40.25× | Reported |
| 2012-06-30 | (m) | $671.72M | $949.00K | $74.93M | $2.17M | (m) | 0.14% | 34.50× | Reported |
| 2012-03-31 | (m) | $647.23M | $1.01M | $73.15M | $2.12M | (m) | 0.16% | 34.52× | Reported |
| 2011-12-31 | (m) | $615.22M | $1.06M | $66.94M | $2.20M | (m) | 0.17% | 30.47× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $460.41M | $895.00K | $56.44M | $2.12M | (m) | 0.19% | 26.67× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $409.46M | $947.00K | $44.80M | $2.65M | (m) | 0.23% | 16.93× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COTY INC. (COTY) | United States | $2.307B | -3.15 |
| e.l.f. Beauty, Inc. (ELF) | United States | $5.934B | |
| EDGEWELL PERSONAL CARE Co (EPC) | United States | $1.261B | -13.27 |
| SOLESENCE, INC. (SLSN) | United States | $0.058B | -25.13 |
| Axil Brands, Inc. (AXIL) | United States | $0.042B | 17.24 |
| UNITED GUARDIAN INC (UG) | United States | $0.034B | 13.30 |
| Caring Brands, Inc. (CABR) | United States | $0.013B | |
| BONK, INC. (BNKK) | United States | $0.011B | -0.14 |
| cbdMD, Inc. (YCBD) | United States | $0.005B | -2.59 |
| Kenvue Inc. (KVUE) | United States | $33.844B | 22.14 |